"Scientists Identify Key Protein That Can Reverse Deadly Heart Condition"
An international team of scientists has identified a key protein, CCN5, that has the potential to reverse established cardiac fibrosis, the abnormal thickening of the heart valves, which progresses to heart failure. "Our research is the first to demonstrate the ability to reverse cardiac fibrosis in heart failure models by targeting a specific gene," said lead researcher Roger Hajjar, MD, a professor of cardiology and director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai. Learn more.
Skipping Breakfast May Compromise the Immune System
Feb 23, 2023 View All Press Releases
Valentin Fuster, MD, PhD, Receives Prestigious Award from City of Barcelona, Spain
Jan 23, 2023 View All Press Releases
Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai
Dec 20, 2022 View All Press Releases
Samin Sharma, MD, Named Director of the Mount Sinai Cardiovascular Clinical Institute
Nov 28, 2022 View All Press Releases
Blinding Eye Disease Strongly Associated With Serious Forms of Cardiovascular Disease
Nov 17, 2022 View All Press Releases